Prepare the Pen Take the pen out of the refrigerator about 30 minutes before injection to allow it to reach room temperature. Do not heat the pen or expose it to direct sunlight. Check the solution — it should be clear, colorless, and free of particles. Wash Your Hands Clean your hands thoroughly with soap and water. Choose Injection Site Common sites are the front of your thighs, abdomen (except around the navel), or the upper arm (if someone else is giving the injection). Rotate the injection site each week to avoid irritation. Prepare the Pen for Injection Remove the pen cap. Check the dose window to confirm the correct dose (2.5 mg in this case). Inject the Dose Pinch the skin lightly. Insert the needle under the skin at a 90-degree angle. Press the injection button firmly and hold it until the dose counter shows zero (usually takes a few seconds). Keep the needle in place for about 5-10 seconds to ensure the full dose is delivered. Remove the Needle Withdraw the needle straight out. Replace the pen cap immediately. Dispose of the used needle safely in a sharps container. After Injection You can gently press or massage the injection site if needed. Do not rub the injection site vigorously. Storage After Use Store the pen in the refrigerator if you haven't used all doses. Once taken out and used, the pen can be kept at room temperature (below 30°C/86°F) for up to 21 days.
Mounjaro is a medicine that contains an active substance called tirzepatide. Mounjaro is used to treat adults with type 2 diabetes mellitus by reducing the level of sugar in the body only when the levels of sugar are high. Mounjaro is also used for weight loss and weight maintenance in adults.
Prescription Only: Use Mounjaro only if prescribed by a healthcare professional. Do not share your pen with others. Allergies: Inform your doctor if you have a known allergy to tirzepatide or any ingredients in the pen. Medical History: Tell your healthcare provider if you have a history of: Pancreatitis (inflammation of the pancreas) Medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2) Severe gastrointestinal diseases Kidney or liver problems Injection Site: Rotate injection sites weekly to reduce the risk of skin problems such as irritation or lumps. Hypoglycemia (Low Blood Sugar): Although Mounjaro alone rarely causes low blood sugar, it can if combined with other diabetes medications. Recognize symptoms like dizziness, sweating, shaking, confusion, and treat promptly with fast-acting sugar. Pancreatitis Warning: Stop using Mounjaro and seek medical help immediately if you experience severe abdominal pain, which may radiate to your back, with or without vomiting. Kidney Function: Dehydration caused by nausea, vomiting, or diarrhea can worsen kidney problems; stay hydrated. Pregnancy and Breastfeeding: Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Storage: Keep unused pens refrigerated (2°C to 8°C or 36°F to 46°F). Once in use, pens can be stored at room temperature (below 30°C/86°F) for up to 21 days. Do not freeze or expose to extreme heat. Disposal: Dispose of needles safely in a sharps container to avoid injury and contamination. Side Effects: Common side effects include nausea, vomiting, diarrhea, decreased appetite, and constipation. Report any severe or persistent symptoms to your healthcare provider. Interactions: Inform your healthcare provider about all other medications, supplements, or herbal products you are using.
Effective Blood Sugar Control: Helps significantly reduce HbA1c levels (a measure of long-term blood sugar control) in adults with type 2 diabetes. Supports Weight Loss: Promotes reduced appetite and calorie intake, leading to meaningful weight loss in many patients. Once-Weekly Dosing: Convenient once-a-week injection, improving adherence compared to daily medications. Dual Hormone Action: Targets both GIP and GLP-1 receptors, providing a more comprehensive approach to blood sugar regulation and appetite control than some other diabetes drugs. Reduced Risk of Diabetes Complications: Better blood sugar control helps lower the risk of heart disease, kidney damage, nerve problems, and vision loss associated with diabetes. Improves Insulin Sensitivity: Enhances the body’s response to insulin, helping to regulate blood glucose levels more effectively. Can Be Combined With Other Medications: Often used alongside other diabetes treatments to optimize control. May Improve Cardiovascular Health: Some studies suggest benefits in reducing cardiovascular risks in people with type 2 diabetes.
What is Mounjaro? Mounjaro is a once-weekly injectable medication that helps lower blood sugar in adults with type 2 diabetes. It also promotes weight loss by reducing appetite and slowing gastric emptying. How It Works: Tirzepatide activates two hormones — GIP and GLP-1 — that increase insulin secretion, decrease glucagon, and reduce hunger. Treatment Goals: Improve blood sugar control Support weight management Reduce risk of diabetes-related complications Administration Frequency: Inject once per week on the same day, at any time of day, with or without food. Dose Adjustment: Your doctor may increase your dose gradually based on your response and tolerance. Missed Dose: If you miss a dose, take it as soon as you remember, unless it’s within 3 days of your next scheduled dose. Then skip the missed dose and continue your regular schedule. Lifestyle: Mounjaro is most effective when combined with a healthy diet and regular physical activity. Clinical Benefits: Studies show significant improvements in HbA1c (blood sugar control) and body weight reduction. Consult Healthcare Provider: Always discuss any side effects, new symptoms, or concerns with your doctor promptly. Patient Support: Many manufacturers provide patient education materials, injection technique videos, and adherence tools to support treatment success.
Active Ingredient: Tirzepatide — 2.5 mg per 0.6 ml dose (Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control in type 2 diabetes and support weight loss.)